Inventor
NORDSIEK MICHAEL T
US21 patents
⚠️ This page may combine multiple inventors who share the name “NORDSIEK MICHAEL T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEDICIS PHARMACEUTICAL CORP
10 patentsUS9078889B2Jul 14, 2015
Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
MEDICIS PHARMACEUTICAL CORP6 citations82
US9642998B2May 9, 2017
Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream
MEDICIS PHARMACEUTICAL CORP3 citations72
US10238644B2Mar 26, 2019
2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimod
MEDICIS PHARMACEUTICAL CORP1 citations69
US11850245B2Dec 26, 2023
Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
MEDICIS PHARMACEUTICAL CORP0 citations60
US11202752B2Dec 21, 2021
Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
MEDICIS PHARMACEUTICAL CORP0 citations60
US10918635B2Feb 16, 2021
Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
MEDICIS PHARMACEUTICAL CORP0 citations60
US11318130B2May 3, 2022
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod
MEDICIS PHARMACEUTICAL CORP0 citations59
US10238645B2Mar 26, 2019
Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
MEDICIS PHARMACEUTICAL CORP0 citations50
US9980955B2May 29, 2018
Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
MEDICIS PHARMACEUTICAL CORP0 citations50
US9271973B2Mar 1, 2016
Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
MEDICIS PHARMACEUTICAL CORP0 citations50
NORDSIEK MICHAEL T
8 patentsUS8946276B2Feb 3, 2015
High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
NORDSIEK MICHAEL T15 citations91
US8299109B2Oct 30, 2012
Method of treating actinic keratosis with 3.75% imiquimod cream
NORDSIEK MICHAEL T17 citations90
US8236816B2Aug 7, 2012
2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod
NORDSIEK MICHAEL T12 citations90
US8222270B2Jul 17, 2012
2×2×2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimod
NORDSIEK MICHAEL T13 citations90
US9072876B2Jul 7, 2015
Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream
NORDSIEK MICHAEL T7 citations83
US9370509B2Jun 21, 2016
2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod
NORDSIEK MICHAEL T5 citations82
US8642616B2Feb 4, 2014
Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
NORDSIEK MICHAEL T5 citations82
US9198858B2Dec 1, 2015
Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations
NORDSIEK MICHAEL T3 citations61